Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 843-853

  Schönbeck, Uwe ^a   Mach, François ^a   Sukhova, Galina K ^a   Atkinson, Elizabeth ^a   Levesque, Ethan ^a   Herman, Michael ^a   Graber, Pierre ^b   Basset, Paul ^c   Libby, Peter ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Serono International SA   (Switzerland)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Atherosclerosis; CD40L CD154; Matrix metalloproteinase; Serpins; Stromelysin 3

Indexed keywords

CD40 ANTIGEN; MATRIX METALLOPROTEINASE; STROMELYSIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CATALYSIS; DNA LIBRARY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD40; AORTA; ARTERIOSCLEROSIS; CAROTID ARTERIES; CD40 LIGAND; ENDOTHELIUM, VASCULAR; HUMANS; HYPERLIPIDEMIAS; MACROPHAGES; MATRIX METALLOPROTEINASE 11; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, LDL; SIGNAL TRANSDUCTION;

EID: 0039168853     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.843     Document Type: Article

References (61)

1. Manuel, D., C. Murray, W. Risau, and M. Clauss. 1996. Tumor necrosis: factors and principles. Immunol. Today. 17: 254-256.
2. Moscatelli, D., and D.B. Rifkin. 1988. Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta. 948: 67-85.
3. Rouyer, N., C. Wolf, M.P. Chenard, M.C. Rio, P. Chambon, J.P. Bellocq, and P. Basset. 1995. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis. 14:269-275.
4. Henney, A.M., P.R. Wakeley, M.J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA. 88:8154-8158.
5. Galis, Z.S., G.K. Sukhova, M.W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
6. Brown, D.L., M.S. Hibbs, M. Kearney, C. Loushin, and J.M. Isner. 1995. Identification of 92 kD gelatinase in human coronary atherosclerotic lesions. Circulation. 91:2125-2131.
7. Lee, R.T., and P. Libby. 1996. Metalloproteinases and atherosclerotic plaque rupture. In The Role of Immune Mechanisms. H.-P. Schultheiss and P. Schwimmbeck, editors. Springer Verlag, New York. 21:238-246.
8. Matrisian, L.M. 1992. The matrix-degrading metalloproteinases. Bioessays. 14:455-463.
9. Pei, D., and S.J. Weiss. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375: 244-247.
10. Santavicca, M., A. Noel, H. Angliker, I. Stoll, J.-P. Segain, P. Anglard, M. Chretien, N. Seidah, and P. Basset. 1996. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochem. J. 315:953-958.
11. Basset, P., J.P. Bellocq, C. Wolf, I. Stoll, P. Hutin, J.M. Limacher, O.L. Podhajcer, M.P. Chenard, M.C. Rio, and P. Chambon. 1990. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 348: 699-704.
12. Wagner, S.N., C. Ruhri, K. Kunth, B.U. Holecek, H. Hoefler, and M.J. Atkinson. 1992. Expression of stromelysin-3 in the stromal elements of human basal cell carcinoma. Diag. Mol. Pathol. 1:200-205.
13. Urbanski, S.J., D.R. Edwards, A. Maitland, K.J. Leco, A. Watson, and A.E. Kossakowska. 1992. Expression of matrix metalloproteinase and their inhibitors in primary pulmonary carcinomas. Br. J. Cancer. 66:1188-1194.
14. Polette, M., C. Clavel, P. Birembaut, and Y.A. De Clerck. 1993. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol. Res. Pract. 189:1052-1057.
15. Hähnel, E., J.M. Harvey, R. Joyce, P.D. Robbins, G.F. Sterrett, and R. Hähnel. 1993. Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlation. Int. J. Cancer. 55:1-4.
16. Wolf, C., M.P. Chenard, P. Durand De Grossouvre, J.P. Bell, P. Chambon, and P. Basset. 1992. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J. Investig. Dermatol. 99:870-879.
17. Nawrocki, B., M. Polette, C. Clavel, A. Morrone, J.P. Eschard, J.C. Etienne, and P. Birembaut. 1994. Expression of stromelysin 3 and tissue inhibitors of matrix metalloproteinases, Timp-1 and Timp-2, in rheumatoid arthritis. Pathol. Res. Pract. 190:690-696.
18. Lefebvre, O., C. Wolf, J.M. Limacher, P. Hutin, C. Wendling, M. LeMeur, P. Basset, and M.C. Rio. 1992. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J. Cell Biol. 119:997-1002.
19. Rodgers, W.H., L.M. Matrisian, L.C. Giudice, B. Dsupin, P. Cannon, C. Svitek, F. Gorstein, and K.G. Osteen. 1994. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 94:946-953.
20. Lefebvre, O., C. Regnier, M.P. Chenard, C. Wendling, P. Chambon, P. Basset, and M.C. Rio. 1995. Developmental expression of mouse stromelysin-3 mRNA. Development. 121:947-955.
21. Noël, A., M. Santavicca, I. Stoll, C. L'Hoir, A. Staub, G. Murphy, M.C. Rio, and P. Basset. 1995. Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. Biol. Chem. 270: 22866-22872.
22. Murphy, G., J.-P. Segain, M. O'Shea, M. Cockett, C. Ioannou, O. Lefebvre, P. Chambon, and P. Basset. 1993. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J. Biol. Chem. 268:15435-15441.
23. Pei, D., G. Majmudar, and S.J. Weiss. 1994. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269:25849-25855.
24. Potempa, J., E. Korzus, and J. Travis. 1994. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:15957-15960.
25. Beatty, K., J. Bieth, and J. Travis. 1990. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255:3931-3934.
26. Duranton, J., C. Adam, and J.G. Bieth. 1998. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor. Biochemistry. 37: 11239-11245.
27. Janciauskiene, S., O. Al Rayyes, C.-H. Floren, and S. Eriksson. 1997. Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsin. Scand. J. Clin. Lab. Investig. 57:325-336.
28. Kasza, A., H.H. Petersen, C.W. Heegaard, K. Oka, A. Christensen, A. Dubin, L. Chan, and P.A. Andreasen. 1997. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low density-lipoprotein-receptor-related protein. Eur. J. Biochem. 248:270-281.
29. Janciauskiene, S., S. Lindgren, and H.T. Wright. 1998. The C-terminal peptide of alpha-1-antitrypsin increases low density lipoprotein binding in HepG2 cells. Eur. J. Biochem. 254: 460-467.
30. Scharpe, S., M. Eid, W. Cooreman, and A. Lauwers. 1976. Alpha-1-Anti-trypsin, an inhibitor of renin. Biochem. J. 153: 505-507.
31. Pratt, C.W., and F.C. Church. 1993. General features of the heparin-binding serpins antithrombin, heparin cofactor II, and protein C inhibitor. Blood. 4:479-490.
32. Schick, C., Y. Kamachi, A.J. Bartuski, S. Cataltepe, N.M. Schechter, P.A. Pemberton, and G.A. Silverman. 1997. Squamous cell carcinoma-antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 272:1849-1855.
33. Oleksyszyn, J., and A.J. Augustine. 1996. Plasminogen modulation of IL1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors, PAI-1, alpha-2-antiplasmin, alpha-1-PI, alpha-2-macroglobulin and TIMP. Inflamm. Res. 45:464-472.
34. Hornebeck, W., and L. Robert. 1977. Elastase-like enzymes in aortas and human breast carcinomas: quantitative variations with age and pathology. Adv. Exp. Med. Biol. 79:145-164.
35. Mohacsi, A., T. Fulop, B. Kozlovszky, M. Hauck, I. Kiss, and A. Leovey. 1992. Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages. J. Gerontol. 47:154-158.
36. O'Brien, J.R., M.D. Etherington, S. Jamieson, P. Lawford, S.V. Lincoln, and N.J. Alkjaersig. 1975. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb. Diath. Haemorrh. 34:483-497.
37. Ali, M.N., W. Mazur, N.S. Kleinman, G.P. Rodgers, J.M. Abukhalil, B.A. French, and A.E. Raizner. 1996. Inhibition of coronary restenosis by antithrombin III in atherosclerotic swine. Coron. Artery Dis. 7:851-861.
38. Lucas, A., L. Liu, J. Macen, P. Nash, E. Dai, M. Stewart, K. Graham, W. Etches, L. Boshkov, P.N. Nation, et al. 1996. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation. 94:2890-2900.
39. Okada, A., J.-P. Bellocq, N. Rouyer, M.-P. Chenard, M.C. Rio, P. Chambon, and P. Basset. 1995. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA. 92:2730-2734.
40. Anglard, P., T. Melot, E. Guerin, G. Thomas, and P. Basset. 1995. Structure and promotor characterization of the human stromelysin-3 gene. J. Biol. Chem. 270:20337-20344.
41. Mach, F., U. Schönbeck, G.K. Sukhova, T. Bourcier, J.-Y. Bonnefoy, J.S. Pober, and P. Libby. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA. 94:1931-1937.
42. Schönbeck, U., F. Mach, G.K. Sukhova, C. Murphy, J.-Y. Bonnefoy, R.P. Fabumni, and P. Libby. 1997. Regulation of matrix-metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ. Res. 81:448-454.
43. Mach, F., U. Schönbeck, J.-Y. Bonnefoy, J.S. Pober, and P. Libby. 1997. Activation of monocyte/macrophage function related to acute atheromata complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96:396-399.
44. Mazzei, G.J., M.D. Edgerton, C. Losberger, S. Lecoanet-Henchoz, P. Graber, A. Durandy, J.-F. Gauchat, A. Bernard, B. Allet, and J.-Y. Bonnefoy. 1995. Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270:7025-7028.
45. Santavicca, M., A. Noel, M.-P. Chenhard, Y. Lutz, I. Stoll, J.-P. Segain, N. Rouyer, M.C. Rio, C. Wolf, J.-P. Belloco, and P. Basset. 1995. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry. Int. J. Cancer. 64:336-341.
46. Kennedy, M.K., K.S. Picha, W.C. Fanslow, K.H. Grabstein, M.R. Alderson, K.N. Clifford, W.A. Chin, and K.M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370-378.
47. Ross, R., and B. Kariya. 1980. Morphogenesis of vascular smooth muscle in atherosclerosis and cell structure. In Handbook of Physiology, The Cardiovascular System. D.F. Bohr, A.P. Somlyo, and H.Y. Sparks, editors. American Physiological Society, Bethesda, MD. 66-91.
48. Libby, P., and K.V. O'Brien. 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J. Cell. Physiol. 115:217-223.
49. Böyum, A. 1968. Isolation of mononuclear cells and granulo-cytes from human blood. Scand.J. Clin. Lab. Investig. 21:77-89.
50. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
51. Mach, F., U. Schönbeck, G.K. Sukhova, E. Atkinson, and P. Libby. 1998. Reduction of atherosclerosis in a mouse model by interruption of CD40-CD40L signaling. Nature. 394: 200-203.
52. Guerin, E., M.-G. Ludwig, P. Basset, and P. Anglard. 1997. Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. J. Biol. Chem. 272:11088-11095.
53. Mari, B.P., I.C. Anderson, S.E. Man, Y. Ning, Y. Lutz, L. Kobzik, and M.A. Shipp. 1998. Stromelysin-3 is induced in tumor/stroma cocultures and inactivated via a tumor-specific and basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273:618-626.
54. Wolf, C., N. Rouyer, Y. Lutz, C. Adida, M. Loriot, J.P. Bell, P. Chambon, and P. Basset. 1993. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. Natl. Acad. Sci. USA. 90:1843-1847.
55. Mucha, A., P. Cuniasse, R. Kannan, F. Beau, A. Yiotakis, P. Basset, and V. Dive. 1998. Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently substrates containing unusual amino acids in their P1′ positions. J. Biol. Chem. 273:2763-2768.
56. Grant, M.B., T.J. Wargovich, E.A. Ellis, R. Tarnuzzer, S. Caballero, K. Estes, M. Rossing, P.E. Spoerri, and C. Pepine. 1996. Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4, and -5 in human atheroectomy specimens. Regul. Pept. 67:137-144.
57. Delafontaine, P. 1995. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 30:825-834.
58. Motomura, N., H. Lou, P. Maurice, and M.L. Foegh. 1997. Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I. Transplantation. 63:932-936.
59. Manes, S., E. Mira, M.M. Barbacid, A. Cipres, P. Fernandez-Resa, J.M. Buesa, I. Merida, M. Aracil, G. Marquez, and A.C. Martinez. 1997. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J. Biol. Chem. 272:25706-25712.
60. Bennett, M.R., G.I. Evan, and S.M. Schwartz. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaque. J. Clin. Invest. 95:2266-2274.
61. van der Bom, J.G., M.L. Bots, H.H. van Vliet, H.A. Pols, A. Hofman, and D.E. Grobbee. 1996. Antithrombin and atherosclerosis in the Rotterdam Study. Arterioscler. Thromb. Vasc. Biol. 16:864-867.